Recent Finacing
Recent Raise
BioLineRx develops APHEXDA (motixafortide) for stem cell mobilization, advancing clinical programs in sickle cell disease and metastatic pancreatic cancer while pursuing US commercialization and Asia expansion with partner Gloria Biosciences.
